Search

Your search keyword '"Lassen, Jens Flensted"' showing total 71 results

Search Constraints

Start Over You searched for: Author "Lassen, Jens Flensted" Remove constraint Author: "Lassen, Jens Flensted" Publisher elsevier bv Remove constraint Publisher: elsevier bv
71 results on '"Lassen, Jens Flensted"'

Search Results

3. Optimal lesion preparation before implantation of a Magmaris bioresorbable scaffold in patients with coronary artery stenosis: Rationale, design and methodology of the OPTIMIS study

4. Coronary angiography in patients with kidney dysfunction and myocardial injury: A retrospective cohort study on management of myocardial injury in hospitalized patients with kidney disease

5. Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions

6. Optimal Lesion Preparation Before Implantation of a Magmaris Bioresorbable Scaffold in Patients with Coronary Artery Stenosis: Rationale, Design and Methodology of the OPTIMIS Study

7. Optical Coherence Tomography- Versus Angiography-Guided Magnesium Bioresorbable Scaffold Implantation in NSTEMI Patients

8. Physiological Approach for Coronary Artery Bifurcation Disease

10. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

11. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

12. Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI

13. Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial

14. Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention

15. A nationwide investigation of CPR courses, books, and skill retention

16. Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study

17. Thrombus aspiration and prehospital ticagrelor administration in ST-elevation myocardial infarction: Findings from the ATLANTIC trial

18. Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study

19. CRT-600.05 Intravascular Ultrasound Findings of the Fantom Bioresorbable Scaffold at 6 and 9 Months Follow-up: Results from the Multicenter FANTOM II Study

20. Pre-hospital ticagrelor in ST-segment elevation myocardial infarction in the French ATLANTIC population

22. TCT-29 Performance and healing patterns after implantation of a novel sirolimus eluting bioresorbable scaffold. Six-month follow-up by optical coherence tomography in the FANTOM II study

23. TCT-451 Two-year outcomes after revascularization with a biodegradable polymer ultra-thin strut sirolimus eluting stent and a biodegradable polymer biolimus-eluting stent. From the SORT OUT VII trial

24. TCT-321 Definite and probable stent thrombosis after revascularization with drug-eluting stents with a biodegradable polymer. From the randomized SORT OUT VII Trial

25. TCT-318 Ten-year All-cause Mortality after Simple versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study

26. Quality of Danish CPR courses for laypersons

27. INTERACTION BETWEEN MORPHINE AND TICAGRELOR IN THE ATLANTIC STUDY

28. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

29. Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents

30. Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trial

31. Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction

32. Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

33. Co-registration of optical coherence tomography and X-ray angiography in percutaneous coronary intervention. The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) fusion study

34. Impact of Health Care System Delay in Patients With ST-Elevation Myocardial Infarction on Return to Labor Market and Work Retirement

36. Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial

40. Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS)

41. Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

42. Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study

43. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

44. Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the SORT OUT IV Trial)

45. TCT-355 Coronary Stents In Patients With Diabetes Mellitus: The Diabetes And Drug-Eluting Stent (DiabeDES IV) Randomized Angiography Trial

46. TCT-347 Clinical Outcome Of Biolimus-Eluting Versus Sirolimus-Eluting Coronary Stent Implantation In Patients With And Without Diabetes Mellitus: A SORT OUT V Substudy

47. TCT-297 Stent edge dissections detected by Optical Coherence Tomography, incidence, predictors and 12-month outcome

48. TCT-283 Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound Trial

49. 2-Year Patient-Related Versus Stent-Related Outcomes

50. 3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Catalog

Books, media, physical & digital resources